SpyGlass Pharma SGP
NASDAQ SGP
$34.18 -4.19 (-10.92%)
At close: Nov 10, 2026 · 4:00 PM EST

SpyGlass Pharma (SGP) Cash from Operations (2025 - 2026)

Updated

SpyGlass Pharma's Cash from Operations was -$32.7 million in FY2025, compared with -$22.03 million in FY2024.

Analysis

SpyGlass Pharma (SGP) Cash from Operations (2025 - 2026) Analysis & Trends

  • Per Business Quant data, Cash from Operations in earlier years was -$22.03 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 11.40 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 7.72 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 7.61 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 6.56 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 5.88 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 4.24 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 5.04 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 5.38 Bn
10 SpyGlass Pharma 1.25 Bn 636.40 Mn - -14.86 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -14.86 Mn
Mar 31, 2026 -13.54 Mn
Jun 30, 2025 -6.33 Mn
Mar 31, 2025 -8.20 Mn
API Access

SpyGlass Pharma Cash from Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-operations&ticker=SGP&period=max&api_key=YOUR_API_KEY